Direkt zum Inhalt
Merck
  • Antibiotic-resistant genes and antibiotic-resistant bacteria in the effluent of urban residential areas, hospitals, and a municipal wastewater treatment plant system.

Antibiotic-resistant genes and antibiotic-resistant bacteria in the effluent of urban residential areas, hospitals, and a municipal wastewater treatment plant system.

Environmental science and pollution research international (2014-10-18)
Jianan Li, Weixiao Cheng, Like Xu, P J Strong, Hong Chen
ZUSAMMENFASSUNG

In this study, we determined the abundance of 8 antibiotics (3 tetracyclines, 4 sulfonamides, and 1 trimethoprim), 12 antibiotic-resistant genes (10 tet, 2 sul), 4 antibiotic-resistant bacteria (tetracycline, sulfamethoxazole, and combined resistance), and class 1 integron integrase gene (intI1) in the effluent of residential areas, hospitals, and municipal wastewater treatment plant (WWTP) systems. The concentrations of total/individual targets (antibiotics, genes, and bacteria) varied remarkably among different samples, but the hospital samples generally had a lower abundance than the residential area samples. The WWTP demonstrated removal efficiencies of 50.8% tetracyclines, 66.8% sulfonamides, 0.5 logs to 2.5 logs tet genes, and less than 1 log of sul and intI1 genes, as well as 0.5 log to 1 log removal for target bacteria. Except for the total tetracycline concentration and the proportion of tetracycline-resistant bacteria (R (2) = 0.330, P < 0.05), there was no significant correlation between antibiotics and the corresponding resistant bacteria (P > 0.05). In contrast, various relationships were identified between antibiotics and antibiotic resistance genes (P < 0.05). Tet (A) and tet (B) displayed noticeable relationships with both tetracycline and combined antibiotic-resistant bacteria (P < 0.01).

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Actidion, from microbial, ≥94% (TLC)
Sigma-Aldrich
Cycloheximid -Lösung, Ready-Made Solution, microbial, 100 mg/mL in DMSO, Suitable for cell culture
Sigma-Aldrich
Cycloheximid, ≥95% (HPLC)
Sigma-Aldrich
Trimethoprim, ≥98.5%
Sigma-Aldrich
Tetracyclin, 98.0-102.0% (HPLC)
Sigma-Aldrich
Tetracyclin, 98.0-102.0% (HPLC)
Sigma-Aldrich
Actidion, Biotechnology Performance Certified
Sigma-Aldrich
Trimethoprim, ≥99.0% (HPLC)
Supelco
Sulfamethoxazol
Supelco
Sulfamethoxazol, Pharmaceutical Secondary Standard; Certified Reference Material
Millipore
Cycloheximid -Lösung, 0.1%, suitable for microbiology
Supelco
Trimethoprim, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Sulfamethoxazol, VETRANAL®, analytical standard
USP
Sulfamethoxazol, United States Pharmacopeia (USP) Reference Standard
Supelco
Trimethoprim, VETRANAL®, analytical standard
USP
Trimethoprim, United States Pharmacopeia (USP) Reference Standard
Supelco
Actidion, PESTANAL®, analytical standard
Sulfamethoxazol, European Pharmacopoeia (EP) Reference Standard
Supelco
Sulfamethoxazol, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Trimethoprim, European Pharmacopoeia (EP) Reference Standard